Asia Pacific Cosmetic Surgery Market
Asia Pacific Cosmetic Surgery Market Size Grows at Steady CAGR of 3.1% to Surpass USD 5.09 Billion by 2030
Published | 08 February 2024
Asia Pacific Cosmetic Surgery Market is flourishing because of the people’s growing aspiration for heightened beauty standards, increasing disposable income, and easy accessibility to cosmetic procedures.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Cosmetic Surgery Market size at USD 4.11 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Asia Pacific Cosmetic Surgery Market size to expand at a CAGR of 3.1% reaching a value of USD 5.09 billion by 2030. Technological improvements in the cosmetic surgery field, along with the rising impact of pop culture and strict beauty standards, are major driving factors for the Asia Pacific Cosmetic Surgery Market. The market is also expected to be driven by advantageous reimbursement policies and the growing popularity of non-invasive treatments.
Opportunity: Flourishing medical tourism in Asia Pacific
Major Asia Pacific countries, such as China, and India, have established themselves as favorable medical tourism destinations for various medical procedures, including cosmetic surgeries. Medical tourists from places like South Korea, Thailand, and Malaysia are drawn to procedures like liposuction, facelifts, rhinoplasty, and breast augmentation. In comparison to Western nations, Asia Pacific provides superior cosmetic procedure at more reasonable pricing and is home to a large number of beauty clinics. The demand for cosmetic surgery among medical tourists in the Asia Pacific region is expected to increase due to improved affordability and high quality cosmetic treatment services.
Asia Pacific Cosmetic Surgery Market
Asia Pacific Cosmetic Surgery Market – By Product Type
Based on product type, the Asia Pacific Cosmetic Surgery Market is segmented into implants, injectables, equipment, surgical sutures skin staplers, and others. Injectables hold the largest share in the Asia Pacific cosmetic surgery by product type. Cosmetic injectables are used for non-invasive procedures and are most prominently used to deal with visible wrinkles on the skin, sunken cheeks and facial lines. They are highly efficient at enhancing the natural features of a person and restoring their lost volumes. Implants also cover a substantial market share owing to the increasing number of breast augmentation surgeries in Asia Pacific.
Asia Pacific Cosmetic Surgery Market – By Country
The in-depth research report on the Asia Pacific Cosmetic Surgery Market covers the market in the regions’ major countries, including China, India, Japan, South Korea, Australia and New Zealand, Indonesia, Malaysia, Singapore, Vietnam, and rest of APAC. South Korea is known as the ‘plastic surgery capital of the world’ and, therefore, dominates the Asia Pacific Cosmetic Surgery Market. The overemphasis on ‘natural beauty’ and rising demand for cosmetic surgery among teens owing to the rising influence of K-pop are boosting the market growth in South Korea. Furthermore, flourishing medical tourism for cosmetic surgery as a result of the growing popularity of K-beauty trends is anticipated to proliferate in the cosmetic surgery market over the forecast period.
Major players operating in the Asia Pacific Cosmetic Surgery Market include Alma Lasers Ltd, Sinclair, Allergan, Cynosure, Cutera Inc., Lumenis Ltd, Candela Corporation, Galderma Laboratories, AbbVie Inc., and Bausch Health Companies Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Asia Pacific Cosmetic Surgery Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Asia Pacific Cosmetic Surgery Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- Asia Pacific Cosmetic Surgery Market, By Procedure (Facial Procedures, Body Contouring Procedures, Breast Procedures, Genital Rejuvenation, Non-Surgical Procedures, Others); By Product Type (Implants, Injectables, Equipment, Surgical Sutures & Skin Staplers, Others); By End User (Ambulatory Surgical Units, Hospitals & Clinics, Cosmetic Surgical Centers, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
Publish Date: February 2024
Growing aspirations to meet the higher beauty standards driven by the popular K-pop culture, increasing disposable income, and accessibility to cosmetic procedures are expected to boost the growth of Asia Pacific Cosmetic Surgery Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- Blood Bag Market has reached USD 290 Million in 2019 and is further projected to reach USD 629.17 Million by 2026
- Asia Pacific Stem Cell Therapy Market Size Expands at Significant CAGR of 10.48% to Surpass USD 5 Billion by 2030
- India Medical Gloves Market Registers Unwavering Growth: Projected to Grow at a CAGR of 11.4% by 2028
- Global Lipid Metabolism Disease Drug Market Size Expands at Significant CAGR of 7.1% to Reach USD 24.44 Billion by 2029
- India Dietary Supplements Market Size Zooming 2.6X at Robust CAGR of 14.7% to Touch USD 13.1 Billion by 2029